Welcome to kongre.net
Speaker
Co-Founder & Chief Scientific Officer, Monument Therapeutics
Kiri Granger, Co-Founder & Chief Scientific Officer at Monument Therapeutics, is speaking at Novel CNS Biomarkers Summit Europe (London, United Kingdom, 30 Nov – 2 Dec 2026) in the session “Moving Beyond Symptom-Based Psychiatry: Using Digital Cognitive Biomarkers to Stratify Patients, Confirm Pharmacology & Advance Precision Medicine in Schizophrenia”.
30 Nov – 2 Dec 2026London, United Kingdom
President & Chief Executive Officer, Progenra Inc
Vice President - Translational Biology, NRG Therapeutics
Neurological Disorders & Biofluid Specialist, Lundbeck
Founder & Chief Executive Officer, AltPep
Senior Scientist, Biosample Project Leader, Roche
Global Program Head Neurology, Duke University
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Kiri Granger, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].